Baike Biotech: Changchun Baike Biotech Co., Ltd. 2024 Annual Performance Report Announcement

SZSIFeb 26 00:00 · Announcements

Changchun Baike Biotechnology Co., Ltd. 2024 Annual Performance Report Announcement

SZSIFeb 26 00:00 · Announcements

Express News | Baike Biological: Appointed Sun Wanfeng as deputy general manager.

BreakingsFeb 25 15:48

Baike Biological (688276.SH): Net income for the fiscal year 2024 decreased by 52.31% year-on-year.

On February 25, Glonghui reported that Baike Biotechnology (688276.SH) released its performance quick report for the fiscal year 2024. During the reporting period, total operating revenue was 1.229 billion yuan, a year-on-year decrease of 32.64%; net income attributable to the parent company was 0.239 billion yuan, a year-on-year decrease of 52.31%; net income attributable to the parent company after deducting non-recurring gains and losses was 0.237 billion yuan, a year-on-year decrease of 52.06%. The performance changes in 2024 were mainly affected by factors such as the reduced willingness of the public to get vaccinated and decreased market demand, significantly impacting the sales and use of the company's live attenuated varicella vaccine.

Gelonghui FinanceFeb 25 15:48

Changchun BCHT Biotechnology Deputy General Manager Quits

MT NewswiresFeb 18 19:07

Express News | Baike Biological: Director and Deputy General Manager Yu Bing resigned for personal reasons.

BreakingsFeb 14 16:37